Brief: Predictive Oncology Announces Agreement To Be Acquired By Renovaro
Jan 6 (Reuters) - Predictive Oncology Inc POAI.O :
* PREDICTIVE ONCOLOGY ANNOUNCES AGREEMENT TO BE ACQUIRED BY
RENOVARO
* PREDICTIVE ONCOLOGY INC - MERGER EXPECTED TO REDUCE
OPERATING
EXPENSES BY OVER 30%
* PREDICTIVE ONCOLOGY INC - PREFERRED STOCK ISSUED IN 1:1
EXCHANGE
FOR PREDICTIVE ONCOLOGY COMMON STOCK
* PREDICTIVE ONCOLOGY INC - RENOVARO CAN REDEEM PREFERRED
STOCK
FOR $3.00 PER SHARE
Source text: ID:nGNX7XtbNz
Further company coverage: POAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing